Moody National Bank Trust Division Biomarin Pharmaceutical Inc Transaction History

Moody National Bank Trust Division

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$85.07 - $94.48 $176,009 - $195,479	2,069 Added 56.18%	5,752 $508,000
Q2 2023 Jul 07, 2023	BUY	$86.68 - $100.3 $13,348 - $15,446	154 Added 4.36%	3,683 $319,000
Q1 2023 Apr 19, 2023	SELL	$87.74 - $117.27 $877 - $1,172	-10 Reduced 0.28%	3,529 $343,000
Q4 2022 Jan 11, 2023	SELL	$80.93 - $108.63 $971 - $1,303	-12 Reduced 0.34%	3,539 $367,000
Q2 2022 Jul 07, 2022	SELL	$71.48 - $86.85 $244,819 - $297,461	-3,425 Reduced 49.1%	3,551 $294,000
Q1 2022 Apr 12, 2022	SELL	$74.28 - $92.69 $70,194 - $87,592	-945 Reduced 11.93%	6,976 $538,000
Q4 2021 Jan 13, 2022	SELL	$71.72 - $91.47 $1.55 Million - $1.98 Million	-21,651 Reduced 73.21%	7,921 $700,000
Q3 2021 Oct 07, 2021	SELL	$74.77 - $85.47 $2,990 - $3,418	-40 Reduced 0.14%	29,572 $2.29 Million
Q2 2021 Jul 13, 2021	SELL	$75.51 - $84.79 $3,775 - $4,239	-50 Reduced 0.17%	29,612 $2.47 Million
Q1 2021 Apr 14, 2021	SELL	$74.73 - $90.69 $2,092 - $2,539	-28 Reduced 0.09%	29,662 $2.24 Million
Q4 2020 Mar 04, 2021	SELL	$72.61 - $90.2 $5,808 - $7,216	-80 Reduced 0.27%	29,690 $2.6 Million
Q1 2019 Apr 11, 2019	SELL	$84.2 - $98.62 $842 - $986	-10 Reduced 0.03%	29,770 $2.65 Million
Q3 2018 Oct 31, 2018	BUY	$93.92 - $105.72 $2.49 Million - $2.81 Million	26,555 Added 823.41%	29,780 $2.89 Million
Q1 2018 Apr 16, 2018	SELL	$77.67 - $92.63 $5,048 - $6,020	-65 Reduced 1.98%	3,225 $262,000
Q3 2017 Oct 12, 2017	BUY	$80.6 - $94.95 $265,174 - $312,385	3,290	3,290 $306,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.